NCT03312530 2023-02-28A Study of Cobimetinib Administered as Single Agent and in Combination With Venetoclax, With or Without Atezolizumab, in Participants With Relapsed and Refractory Multiple MyelomaHoffmann-La RochePhase 1/2 Completed49 enrolled 24 charts